Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
IZEA
|
Edward H Murphy
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 12,450 Added 2.51% |
-
|
Dec 31
2020 |
IZEA
|
Ryan S Schram
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,642 Added 4.52% |
-
|
Dec 31
2020 |
PFIE
|
Jay Grant Fugal
VP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct | 799 Reduced 1.96% |
-
|
Dec 31
2020 |
PFIE
|
Ryan W Oviatt
Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,913 Reduced 0.99% |
-
|
Dec 31
2020 |
PFIE
|
Patrick David Fisher
VP of Product Development |
SELL
Payment of exercise price or tax liability
|
Direct | 1,105 Reduced 1.04% |
-
|
Dec 31
2020 |
PFIE
|
Cameron M. Tidball
Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,755 Reduced 0.81% |
-
|
Dec 31
2020 |
UBFO
|
Dennis R Woods
CEO |
BUY
Other acquisition or disposition
|
Indirect | 0 Added 0.0% |
-
|
Dec 31
2020 |
UBFO
|
Dennis R Woods
CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 5,834 Added 0.69% |
-
|
Dec 31
2020 |
UBFO
|
Dennis R Woods
CEO |
BUY
Other acquisition or disposition
|
Direct | 0 Added 0.0% |
-
|
Dec 31
2020 |
UBFO
|
William M. Yarbenet
SVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct | 5,834 Added 20.56% |
-
|
Dec 31
2020 |
UBFO
|
Bhavneet Gill
SVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 5,834 Added 13.94% |
-
|
Dec 31
2020 |
UBFO
|
David L Eytcheson
SVP & COO |
BUY
Other acquisition or disposition
|
Indirect | 0 Added 0.0% |
-
|
Dec 31
2020 |
UBFO
|
David L Eytcheson
SVP & COO |
BUY
Exercise of conversion of derivative security
|
Direct | 5,834 Added 3.47% |
-
|
Dec 31
2020 |
UBFO
|
Robert C Oberg Jr
SVP & CHIEF RISK OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 5,833 Added 26.05% |
-
|
Dec 31
2020 |
FNCB
|
Keith W. Eckel
Director |
BUY
Other acquisition or disposition
|
Direct | 36 Added 0.27% |
$244
$6.77 p/Share
|
Dec 31
2020 |
XAIR
|
Steven A. Lisi
CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct | 38,500 Added 97.64% |
$203,280
$5.28 p/Share
|
Dec 31
2020 |
LCTX
|
Brian M Culley
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,343 Reduced 2.8% |
$9,404
$1.76 p/Share
|
Dec 31
2020 |
LCTX
|
Brian M Culley
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,450 Added 7.49% |
$27,192
$1.76 p/Share
|
Dec 31
2020 |
CBNK
|
Alan W Jackson
Executive VP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,500 Added 11.63% |
-
|
Dec 31
2020 |
CBNK
|
Randall James Levitt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 900 Added 18.0% |
-
|
Dec 31
2020 |
CBNK
|
Michael Joseph Burke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 846 Added 0.48% |
-
|
Dec 31
2020 |
CBNK
|
Deborah Ratnersalzberg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 792 Added 2.9% |
-
|
Dec 31
2020 |
CBNK
|
Stephen N Ashman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 846 Added 26.69% |
-
|
Dec 31
2020 |
CBNK
|
Steven Jay Schwartz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,440 Added 9.65% |
-
|
Dec 31
2020 |
CBNK
|
C Scott Brannan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 846 Added 50.0% |
-
|
Dec 31
2020 |
CBNK
|
Joshua Bernstein
Director |
BUY
Grant, award, or other acquisition
|
Direct | 990 Added 0.95% |
-
|
Dec 31
2020 |
CBNK
|
James F. Whalen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,440 Added 18.1% |
-
|
Dec 31
2020 |
NTGR
|
Mark G Merrill
CTO |
SELL
Open market or private sale
|
Direct | 12,431 Reduced 19.57% |
$508,552
$40.91 p/Share
|
Dec 31
2020 |
SLP
|
Walter S Woltosz
Director |
SELL
Bona fide gift
|
Direct | 60,000 Reduced 1.29% |
$4,315,200
$71.92 p/Share
|
Dec 31
2020 |
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$875,400
$58.36 p/Share
|
Dec 31
2020 |
ADPT
|
Julie Rubinstein
President and COO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 50.0% |
$94,800
$6.32 p/Share
|
Dec 31
2020 |
ADPT
|
Stacy L Taylor
SVP and General Counsel |
SELL
Open market or private sale
|
Direct | 6,530 Reduced 83.4% |
$381,352
$58.4 p/Share
|
Dec 31
2020 |
ADPT
|
Stacy L Taylor
SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 6,530 Added 45.47% |
$46,885
$7.18 p/Share
|
Dec 31
2020 |
ARNC
|
E Stanley Oneal |
BUY
Grant, award, or other acquisition
|
Direct | 1,132 Added 0.97% |
$33,734
$29.8 p/Share
|
Dec 31
2020 |
CYTK
|
John T Henderson
Director |
SELL
Open market or private sale
|
Direct | 858 Reduced 48.83% |
$17,426
$20.31 p/Share
|
Dec 31
2020 |
CYTK
|
John T Henderson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 858 Added 32.81% |
$11,120
$12.96 p/Share
|
Dec 31
2020 |
MDU
|
Edward A Ryan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 481 Added 1.85% |
$12,492
$25.97 p/Share
|
Dec 31
2020 |
ED
|
Michael W Ranger
Director |
BUY
Grant, award, or other acquisition
|
Direct | 636 Added 0.98% |
$45,169
$71.02 p/Share
|
Dec 31
2020 |
ED
|
Deirdre Stanley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 404 Added 3.31% |
$28,692
$71.02 p/Share
|
Dec 31
2020 |
ED
|
L Frederick Sutherland
Director |
BUY
Grant, award, or other acquisition
|
Direct | 510 Added 0.74% |
$36,220
$71.02 p/Share
|
Dec 31
2020 |
SYY
|
Daniel J Brutto
Director |
BUY
Grant, award, or other acquisition
|
Direct | 221 Added 1.0% |
$16,197
$73.29 p/Share
|
Dec 31
2020 |
SYY
|
John M Cassaday
Director |
BUY
Grant, award, or other acquisition
|
Direct | 170 Added 0.31% |
$12,459
$73.29 p/Share
|
Dec 31
2020 |
SYY
|
Larry C Glasscock
Director |
BUY
Grant, award, or other acquisition
|
Direct | 238 Added 0.33% |
$17,443
$73.29 p/Share
|
Dec 31
2020 |
SYY
|
John M Hinshaw
Director |
BUY
Grant, award, or other acquisition
|
Direct | 341 Added 2.98% |
$24,992
$73.29 p/Share
|
Dec 31
2020 |
SYY
|
Hans Joachim Koerber
Director |
BUY
Grant, award, or other acquisition
|
Direct | 170 Added 0.29% |
$12,459
$73.29 p/Share
|
Dec 31
2020 |
EQIX
|
Keith D Taylor
Chief Financial Officer |
SELL
Bona fide gift
|
Direct | 13,500 Reduced 45.51% |
-
|
Dec 31
2020 |
RSSS
|
Bristol Investment Fund LTD |
SELL
Open market or private sale
|
Direct | 183,493 Reduced 6.63% |
$418,364
$2.28 p/Share
|
Dec 31
2020 |
MEI
|
Ronald L.G. Tsoumas
VP Finance and CFO |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 2.23% |
$171,900
$38.2 p/Share
|
Dec 31
2020 |
HEAR
|
Juergen M. Stark
CEO & President |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 26.87% |
$654,000
$21.8 p/Share
|
Dec 31
2020 |
HEAR
|
Juergen M. Stark
CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 21.18% |
$231,600
$7.72 p/Share
|
Dec 31
2020 |